Excerpt from the Mass High Tech report journals
"Now we are in great shape to shorten the timeline it takes for a company to find products," said Urban, President and CEO of Acretia... Industry watchers say that Acretia's business strategy makes sense. The biotech industry is in search of new ways to find and commercialize products, while limiting the costs of the endeavor. Also, there's a need for central sources of data on academic research that could yield new drugs."
~ More Info